Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alberta Health services
With
Pfizer
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histological or cytological diagnosis of adenocarcinoma of the prostate
Metastatic or locally recurrent disease not curable with standard therapy
ECOG performance status 0, 1 or 2
Prior single agent docetaxel or docetaxel combination chemotherapy with a documented PSA or imaging response, and no objective evidence of disease progression at study enrolment
You may not be if
Patients with a history of other invasive cancer, except adequately treated non
melanoma skin cancer.
Patients with known brain metastases.
History of allergic reactions attributed to compounds of similar chemical or biologic composition to SU011248.
Other serious intercurrent illness or medical condition that might be aggravated by protocol treatment.
